Latest News about JNJ
Recent news which mentions JNJ
From Motley Fool
4 Reasons to Hang On to Your Moderna Stock
May 08, 2021
From Motley Fool
From MarketWatch
From MarketWatch
From Benzinga
Pfizer-BioNTech want full FDA approval for their vaccine — will a ‘yes’ improve vaccine hesitancy?
May 07, 2021
From MarketWatch
EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots
May 07, 2021
From Benzinga
From MarketWatch
From MarketWatch
Four COVID-19 vaccines are being tested in children and teens. Here’s when to expect a shot for different age groups
May 07, 2021
From MarketWatch
From MarketWatch
Four COVID-19 vaccines are being tested in children and teens. Here’s when to expect a shot for different age groups
May 07, 2021
From MarketWatch
From MarketWatch
From MarketWatch
From Motley Fool
From Motley Fool
From MarketWatch
5 Cheap Growth Stocks for Q2 2021
May 06, 2021
From InvestorPlace
Will corporate greed prolong the COVID-19 pandemic?
May 06, 2021
From MarketWatch
From Benzinga
Biden’s move on vaccine patents represents blow for the second-biggest spender on Washington lobbying
May 06, 2021
From MarketWatch
7 Safe Stocks You Can Leave to Your Children
May 06, 2021
From InvestorPlace
From InvestorPlace
Biden Administration Backs Waiving IP Protections For COVID-19 Vaccines, Pharma Industry Rebukes Move
May 06, 2021
From Benzinga
From Motley Fool
Is It Too Late to Buy Johnson & Johnson Stock?
May 06, 2021
From Motley Fool
From Motley Fool
From MarketWatch
From MarketWatch
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.